MedWatch
This article was originally published in The Tan Sheet
Executive Summary
FDA posts message for health professionals Aug. 25 asking them to report any serious adverse events that occur with use of dietary supplements containing GBL, GHB or BD to the MedWatch database. FDA has issued warnings to consumers of the dangers of gamma butyrolactone, gamma hydroxybutyric acid and 1,4 butanediol through "Talk Papers" and flyers sent to health care professional organizations and publications, school boards and health club associations (1"The Tan Sheet" June 28, p. 5). The agency has asked manufacturers to cease marketing dietary supplements containing the ingredients, for which it has safety concerns